Sudeep Pharma receives FDA approval for its 179 Nandesari greenfield facility
India, Oct. 26 -- Sudeep Pharma announced that its new pharma greenfield manufacturing facility at 179 Nandesari, Gujarat, has received approval from the Gujarat Food and Drug Control Administration (FDA), authorising the Company to commence manufacturing operations at the site.The approval marks a significant milestone in the Company's growth journey and confirms that the facility's manufacturing systems, quality controls and compliance framework meet the requirements for commencing manufacturing operations. It reinforces the Company's commitment to strengthening manufacturing capabilities, quality standards and regulatory compliance.With an installed annual capacity of 51,200 MT, the facility represents an important addition to the Compan...
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.